Medical Therapy of Benign Prostatic Hyperplasia: A Review

Abstract

Medical treatment of benign prostatic hyperplasia (BPH) has conventionally been based on alpha blockers and5-alpha reductase inhibitors. There has been a paradigm shift in this concept with the introduction of otheragents. The treatment of BPH should be based not only on the size of prostate and severity of symptoms, butalso on the type of symptoms (predominant storage versus obstructive), probability of progression, and thepresence or absence of sexual dysfunction
Key words: benign prostatic hyperplasia, lower urinary tract symptoms medical therapy